These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17218666)

  • 1. Alternative statistical parameter for high-throughput screening assay quality assessment.
    Sui Y; Wu Z
    J Biomol Screen; 2007 Mar; 12(2):229-34. PubMed ID: 17218666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
    Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
    J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical practice in high-throughput screening data analysis.
    Malo N; Hanley JA; Cerquozzi S; Pelletier J; Nadon R
    Nat Biotechnol; 2006 Feb; 24(2):167-75. PubMed ID: 16465162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D; Makarenkov V
    J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mixture distributions to deconvolute the behavior of "hits" and controls in high-throughput screening data.
    Buxser S; Chapman DL
    Anal Biochem; 2007 Feb; 361(2):197-209. PubMed ID: 17214952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling.
    Woodward PW; Williams C; Sewing A; Benson N
    J Biomol Screen; 2006 Feb; 11(1):5-12. PubMed ID: 16234338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process validation and screen reproducibility in high-throughput screening.
    Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
    J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying biologically active compound classes using phenotypic screening data and sampling statistics.
    Klekota J; Brauner E; Schreiber SL
    J Chem Inf Model; 2005; 45(6):1824-36. PubMed ID: 16309290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical outcomes of applying ensemble machine learning classifiers to High-Throughput Screening (HTS) data analysis and screening.
    Simmons K; Kinney J; Owens A; Kleier DA; Bloch K; Argentar D; Walsh A; Vaidyanathan G
    J Chem Inf Model; 2008 Nov; 48(11):2196-206. PubMed ID: 18983143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling.
    Digan ME; Pou C; Niu H; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):615-23. PubMed ID: 16103416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.